Market Overview

Snap's Brain Drain Continues With Chief Strategy Officer's Exit

Share:
Snap's Brain Drain Continues With Chief Strategy Officer's Exit
Related SNAP
IMX Dips In October, But Investors Remain Bullish
71 Biggest Movers From Friday
Amazon Selects New York And Virginia Locations For HQ2 And 3 (Seeking Alpha)

Yet another high-level executive at Snap Inc (NYSE: SNAP) has announced their departure, and investors are once again left to wonder whether the revolving door is more a sign of management losing faith in the company or a sign the company is headed in a much-needed new direction.

Another One Bites The Dust

Snap announced in a Monday SEC filing that Chief Strategy Officer Imran Khan is stepping down. Snap stock traded lower by 1.7 percent on Monday morning following the news and is now down 33.3 percent year-to-date — and trading within pennies of its all-time low.

Khan is the latest in a series of high-profile Snap departures in the past year, a list that also includes CFO Drew Vollero, head of product Tom Conrad, Snapchat Spectacles lead Mark Randall, head of sales Jeff Lucas and VP of engineering Tim Sehn.

Snap has struggled to gain market traction following its 2017 IPO, and even after a steep decline in share price, analysts are cautious about the outlook for Snap given the highly competitive social media landscape.

In the company’s last earnings report in August, Snap disclosed that it lost 3 million users during the quarter.

In the new filing, Snap said Khan informed the company he is leaving to pursue other opportunities.

“Mr. Khan has confirmed that this transition is not related to any disagreement with us on any matter relating to our accounting, strategy, management, operations, policies or practices (financial or otherwise),” the company said.

How Low Can Snap Go?

CFRA analyst Scott Kessler recently said the executive changes are just one of several headwinds for Snap at the moment.

“We acknowledge a number of significant risks for the company/stock, including competition (and we note that Facebook's Instagram has performed very well, in our opinion) and execution (with issues related to the Snapchat redesign and executive changes, for example),” Kessler said. (See his track record here.) 

After a major sell-off this year, additional downside in the stock is likely limited in the near-term, the analyst said. 

“After a substantial decline in the stock, which closed last year at $14.61 (down by nearly a third in 2018), we anticipate that SNAP will perform in-line with the broader market over the next 12 months,” Kessler said.

CFRA has a Hold rating and $10 price target for Snap stock.

Related Links:

Q2 13F Roundup: How Buffett, Einhorn, Loeb And Others Adjusted Their Portfolio

Citron: Twitter Shares Could Hit '$52 Within 52 Weeks'

Latest Ratings for SNAP

DateFirmActionFromTo
Oct 2018JefferiesMaintainsHoldHold
Oct 2018Canaccord GenuityMaintainsHoldHold
Oct 2018JP MorganDowngradesNeutralUnderweight

View More Analyst Ratings for SNAP
View the Latest Analyst Ratings

Posted-In: CFRA Research Citron ResearchAnalyst Color News Short Sellers Price Target Management Analyst Ratings Best of Benzinga

 

Related Articles (SNAP)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ALRMImperial CapitalUpgrades58.0
ANDXSunTrust Robinson HumphreyDowngrades41.0
CMANomuraDowngrades86.0
CSLLongbow ResearchUpgrades122.0
HBANNomuraDowngrades15.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Mid-Afternoon Market Update: Dow Edges Lower; Acorda Therapeutics Shares Plunge

Nike Earnings Preview: Wedbush Expects Strong Q1, Accelerating Momentum